β-amino alcohols as promising inhibitory candidates against the SARS-CoV-2, A theoretical design based on MD simulation and DFT insights

被引:0
|
作者
Eshghi, Hossein [1 ]
Noroozi-Shad, Nazanin [1 ]
Seddighi, Mohammad Javad [1 ]
Sabet-Sarvestani, Hossein [1 ]
机构
[1] Ferdowsi Univ Mashhad, Fac Sci, Dept Chem, Mashhad, Iran
关键词
Chiral n -amino alcohols; Main-Protease of COVID-19; Molecular docking; DFT insights; Molecular Dynamics Simulation; MOLECULAR-DYNAMICS SIMULATIONS; FREE-ENERGY LANDSCAPES; MAIN PROTEASE; CORONAVIRUS; DOCKING; DERIVATIVES; NELFINAVIR; PROTEINS; MOTIONS;
D O I
10.1016/j.comptc.2024.114872
中图分类号
O64 [物理化学(理论化学)、化学物理学];
学科分类号
070304 ; 081704 ;
摘要
Nelfinavir, as a compound with a Chiral n-amino alcohol unit, is a well-known inhibitor against HIV-protease, studying. The role of heterocyclic derivatives of Nelfinavir as inhibitors against the Main-Protease of COVID19 is the main purpose of this study. To reach a deep understanding, different theoretical approaches including molecular docking, Molecular Dynamic (MD) simulations, and DFT insights are applied in the studies. Investigation of the ligand bioactivity reveals that smaller HOMO/LUMO band gaps and lower chemical hardness (eta), mean stronger interaction with the active site of the Main-Protease for the corresponding n-amino alcohols. Analyzing the efficient interactions in binding energy shows that among the studied Chiral n-amino alcohols, formed Van der Waals interactions via it and alkyl parts of ligands have more remarkable roles in inhibitory effects than hydrogen bonding. Accordingly, molecular mechanics (MM) and polar interactions have the highest contributions to the total energy of residues. Finally, it has been concluded that among the studied derivatives those that contain Dihydroisoquinoline (4b), and Perhydroisoquinoline (4d) heterocyclic rings can be considered as more potent candidates against Main-Protease of COVID-19.
引用
收藏
页数:16
相关论文
共 50 条
  • [21] Inhibitory efficacy and structural insights of Bofutrelvir against SARS-CoV-2 Mpro mutants and MERS-CoV Mpro
    Wang, Weiwei
    Zhou, Xuelan
    Li, Wenwen
    Zeng, Pei
    Guo, Li
    Wang, Qisheng
    Li, Jian
    COMMUNICATIONS BIOLOGY, 2025, 8 (01)
  • [22] Extracellular vesicles: A promising therapy against SARS-CoV-2 infection
    Leyfman, Yan
    Gohring, Greta
    Joshi, Muskan
    Menon, Gayathri Pramil
    Van de Kieft, Alexandra
    del Rivero, Tania
    Bellio, Michael A.
    Mitrani, Maria Ines
    MOLECULAR THERAPY, 2023, 31 (05) : 1196 - 1200
  • [23] Developing inhibitory peptides against SARS-CoV-2 envelope protein
    Bekdash, Ramsey
    Yoshida, Kazushige
    Nair, Manoj S.
    Qiu, Lauren
    Ahdout, Johnathan
    Tsai, Hsiang-Yi
    Uryu, Kunihiro
    Soni, Rajesh K.
    Huang, Yaoxing
    Ho, David D.
    Yazawa, Masayuki
    PLOS BIOLOGY, 2024, 22 (03)
  • [24] Inhibitory activities of marine sulfated polysaccharides against SARS-CoV-2
    Song, Shuang
    Peng, Haoran
    Wang, Qingling
    Liu, Zhengqi
    Dong, Xiuping
    Wen, Chengrong
    Ai, Chunqing
    Zhang, Yujiao
    Wang, Zhongfu
    Zhu, Beiwei
    FOOD & FUNCTION, 2020, 11 (09) : 7415 - 7420
  • [25] Promising Extracellular Vesicle-Based Vaccines against Viruses, Including SARS-CoV-2
    Sabanovic, Berina
    Piva, Francesco
    Cecati, Monia
    Giulietti, Matteo
    BIOLOGY-BASEL, 2021, 10 (02): : 1 - 14
  • [26] Identification of Potent and Safe Antiviral Therapeutic Candidates Against SARS-CoV-2
    Xiao, Xia
    Wang, Conghui
    Chang, De
    Wang, Ying
    Dong, Xiaojing
    Jiao, Tao
    Zhao, Zhendong
    Ren, Lili
    Dela Cruz, Charles S.
    Sharma, Lokesh
    Lei, Xiaobo
    Wang, Jianwei
    FRONTIERS IN IMMUNOLOGY, 2020, 11
  • [27] Venetoclax: a promising repurposed drug against SARS-CoV-2 main protease
    Ghosh, Suvankar
    Bhattacherjee, Debojit
    Satpati, Priyadarshi
    Bhabak, Krishna Pada
    JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS, 2022, 40 (22): : 12088 - 12099
  • [28] Chitosan: A Promising Protective Component Against SARS-CoV-2 and Influenza Virus
    Rahbar, Mohammad Reza
    Galeh, Hadi Esmaeili Gouvarchin
    Khalili, Saeed
    Jahangiri, Abolfazl
    LETTERS IN DRUG DESIGN & DISCOVERY, 2021, 18 (05) : 418 - 421
  • [29] New insights on possible vaccine development against SARS-CoV-2
    Chaudhry, Sundas Nasir
    Hazafa, Abu
    Mumtaz, Muhummad
    Kalsoom, Ume
    Abbas, Saima
    Kainaat, Amna
    Bilal, Shahid
    Zafar, Nauman
    Siddique, Aleena
    Zafar, Ayesha
    LIFE SCIENCES, 2020, 260
  • [30] Insights into Innate Immune Response Against SARS-CoV-2 Infection
    Hutanu, Adina
    Georgescu, Anca Meda
    Andrejkovits, Akos Vince
    Au, William
    Dobreanu, Minodora
    REVISTA ROMANA DE MEDICINA DE LABORATOR, 2021, 29 (03): : 255 - 269